Capital International LTD Abbott Laboratories Transaction History

Capital International LTD

$2.23 Billion
Q3 2024

A detailed history of Capital International LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Capital International LTD holds 138,047 shares of ABT stock, worth $15.8 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

138,047

Previous 138,138 0.07%

Holding current value

$15.8 Million

Previous $14.4 Million 9.65%

% of portfolio

0.71%

Previous 0.69%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $9,106 - $10,749	-91 Reduced 0.07%	138,047 $15.7 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $21,858 - $24,399	-217 Reduced 0.16%	138,138 $14.4 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $4.4 Million - $4.86 Million	40,213 Added 40.97%	138,355 $15.7 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $407,478 - $498,787	4,518 Added 4.83%	98,142 $10.8 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $61,712 - $74,044	-646 Reduced 0.69%	93,624 $9.07 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $273,416 - $304,642	-2,713 Reduced 2.8%	94,270 $10.3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $623,487 - $733,882	6,437 Added 7.11%	96,983 $9.82 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $158,940 - $186,461	1,672 Added 1.88%	90,546 $9.94 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $720,958 - $834,735	7,451 Added 9.15%	88,874 $8.6 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $286,612 - $346,422	2,808 Added 3.57%	81,423 $8.85 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $60,884 - $74,549	-527 Reduced 0.67%	78,615 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $43,747 - $48,397	375 Added 0.48%	79,142 $9.35 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.2 Million - $1.42 Million	11,379 Added 16.89%	78,767 $9.13 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $136,050 - $160,287	-1,250 Reduced 1.82%	67,388 $8.08 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.29 Million - $1.57 Million	14,068 Added 25.78%	68,638 $7.47 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $63,825 - $93,329	1,016 Added 1.9%	54,570 $4.31 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $1.59 Million - $1.77 Million	20,222 Added 60.67%	53,554 $4.65 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $2.45 Million - $2.66 Million	29,963 Added 889.37%	33,332 $2.79 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $79,721 - $96,174	1,311 Added 63.7%	3,369 $247,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $118,479 - $130,765	2,058 New	2,058 $126,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Abbott Laboratories Transaction History